Based on the above analysis of human and mouse transcriptome data, it can be concluded that (Figure 6D) the expression of Lgals3, Ctss, Cd48, and B2m as universal NAFLD markers, gradually increased with the aggravation of NAFLD (Figures 6A, B, D). The gene discussed is CTSS; the disease is metabolic dysfunction-associated steatotic liver disease.